| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Triptonine B; Triptonine B | CFN92116 | 168009-85-6 | C46H49NO22 = 967.9 | 5mg | QQ客服：3257982914 |
| Aquifoliunine E-III; Aquifoliunine E-III | CFN92117 | 220751-20-2 | C36H45NO17 = 763.8 | 5mg | QQ客服：3257982914 |
| 乌木叶碱 E-II; Ebenifoline E-II | CFN92118 | 133740-16-6 | C48H51NO18 = 929.9 | 5mg | QQ客服：215959384 |
| Mayteine; Mayteine | CFN92119 | 104736-05-2 | C43H49NO18 = 867.9 | 5mg | QQ客服：2159513211 |
| 雷公藤宁碱A; Wilfornine A | CFN92120 | 345954-00-9 | C45H51NO20 = 925.9 | 5mg | QQ客服：3257982914 |
| 鬼箭羽碱，叶含卫矛碱; Alatamine | CFN92121 | 41855-33-8 | C41H45NO18 = 839.8 | 5mg | QQ客服：2056216494 |
| 反式石竹烯; trans-Caryophyllene | CFN90502 | 87-44-5 | C15H24 = 204.36 | 20mg | QQ客服：2159513211 |
| trans-3-氧-α-紫罗兰醇; trans-3-Oxo-alpha-ionol | CFN92428 | 896107-70-3 | C13H20O2 = 208.3 | 5mg | QQ客服：1413575084 |
| 1-O-乙酰-6β-O-异丁酰旋覆花内酯; 1-O-Acetyl-6beta-O-Isobutyrylbritannilactone | CFN92598 | 1087072-50-1 | C21H30O6 = 378.5 | 5mg | QQ客服：1413575084 |
| 狭叶依瓦菊素; Ivangustin | CFN92599 | 14164-59-1 | C15H20O3 = 248.3 | 10mg | QQ客服：1457312923 |
| 1beta-羟基土木香内酯; 1beta-Hydroxyalantolactone | CFN92600 | 68776-47-6 | C15H20O3 = 248.3 | 10mg | QQ客服：1413575084 |
| 旋覆花内酯; Britannilactone | CFN92601 | 33620-72-3 | C15H22O4 = 266.3 | 20mg | QQ客服：2159513211 |
| Neobritannilactone B; Neobritannilactone B | CFN92602 | 886990-00-7 | C15H20O3 = 248.3 | 5mg | QQ客服：1413575084 |
| 表莪术呋喃烯酮; Epicurzerenone | CFN92613 | 20085-85-2 | C15H18O2 = 230.3 | 5mg | QQ客服：215959384 |
| 莪术醇; Curcumenol | CFN92614 | 19431-84-6 | C15H22O2 = 234.3 | 20mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)